Aspirin for pre-eclampsia: compelling data on benefit and risk

Lancet. 2007 May 26;369(9575):1765-1766. doi: 10.1016/S0140-6736(07)60713-2.

Authors

James M Roberts¹, Janet M Catov²

Affiliations

¹ Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh, Magee-Womens Research Institute, Pittsburgh, PA 15213, USA; Department of Epidemiology, University of Pittsburgh, Magee-Womens Research Institute, Pittsburgh, PA 15213, USA. Electronic address: rsijmr@mwri.magee.edu.
² Department of Epidemiology, University of Pittsburgh, Magee-Womens Research Institute, Pittsburgh, PA 15213, USA.

PMID: 17512047
DOI: 10.1016/S0140-6736(07)60713-2

No abstract available

Publication types

Comment

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / antagonists & inhibitors
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Aspirin / adverse effects
Aspirin / therapeutic use*
Clinical Trials as Topic
Female
Humans
Pre-Eclampsia / prevention & control*
Pregnancy
Pregnancy Outcome
Risk Assessment

Substances

Anti-Inflammatory Agents, Non-Steroidal
Aspirin